
Natera Secures Medicare Coverage for Signatera® in Lung Cancer Surveillance: A New Milestone in Cancer Diagnostics
Natera’s Signatera Test Gains CMS Coverage for Non-Small Cell Lung Cancer Patients Austin, Texas – Natera, Inc., a leading innovator in cell-free DNA and genetic testing, recently made an important announcement regarding its Signatera test. This test has now met the coverage requirements from the Centers for Medicare & Medicaid Services’ (CMS) Molecular Diagnostics Services…